Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ZIVO
- Price
- 16.00
- Stock movement down
- -1.00 (-5.88%)
- Company name
- Zivo Bioscience Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 56.74M
- Ent value
- 59.16M
- Price/Sales
- 718.06
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -36.91%
- 1 year return
- 100.25%
- 3 year return
- -11.90%
- 5 year return
- -20.95%
- 10 year return
- -10.40%
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ZIVO does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 718.06 |
| Price to Book | - |
| EV to Sales | 748.68 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.55M |
| EPS (TTM) | -4.01 |
| FCF per share (TTM) | -1.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 79.02K |
| Gross profit (TTM) | 26.08K |
| Operating income (TTM) | -13.66M |
| Net income (TTM) | -13.69M |
| EPS (TTM) | -4.01 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 33.01% |
| Operating margin (TTM) | -17289.37% |
| Profit margin (TTM) | -17327.26% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 159.40K |
| Net receivables | 27.79K |
| Total current assets | 436.55K |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 495.59K |
| Accounts payable | 787.60K |
| Short/Current long term debt | 22.03K |
| Total current liabilities | 2.58M |
| Total liabilities | 2.58M |
| Shareholder's equity | -2.08M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.12M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -4.12M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -2762.78% |
| Return on Invested Capital | 664.32% |
| Cash Return on Invested Capital | 200.07% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 13.13 |
| Daily high | 16.00 |
| Daily low | 13.13 |
| Daily Volume | 1K |
| All-time high | 3619.20 |
| 1y analyst estimate | 12.00 |
| Beta | 0.26 |
| EPS (TTM) | -4.01 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| ZIVO | S&P500 | |
| Current price drop from All-time high | -99.56% | -12.89% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 28 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -94.79% | -11.07% |
| Avg time to new high | 228 days | 12 days |
| Max time to new high | 4964 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
56.74M
Marketcap category
Small-cap
Description
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
Employees
8
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner